If youre in NaNo Portland, then youve already seen this post, but for everyone ELSE.... Read on to learn incredible new medical info! Theres no link for this, because it is insider info from shareholders who went to Ocatas quarterly meeting in Boston, which was not open to the public. (There is a LOT about Ocata in my book-- theyre the biotech company that just changed their name from Advanced Cell Technology.) Ocata is the company developing the first cure (or even treatment!) for age-related macular degeneration, a disease that slowly causes blindness for 30 million people in the U.S. and Europe alone. The interim published results for the clinical trials have looked good, but as far as when this treatment might actually come to market... its everybodys guess. But in the quarterly meeting... several attendees have all said the same thing. The drug has orphan treatment approval for a genetic disease caused Stargardts, which has exactly the same effects and eventually causes blindness. But it attacks much younger people, including children as young as six. (Yep, six years old.) AND... the CEO of Ocata said that the drug will be available in the U.K. in 2018. One of the lines of thought on the forums is that the date might be earlier for AMD approval in the U.S, even quite a bit earlier if the drug is fast tracked here... we just dont know. But this is INCREDIBLE!!!~ There has never ever been any kind of treatment for Stargardts before, and now there will be, and it will be STEM CELL BASED. As of now, that will be the first drug approved anywhere in the WORLD that is embryonic stem cell based. YES! ITS THE START OF A NEW ERA IN MEDICINE!!! And it will be in the book! (sorry about the capslock...
Posted on: Fri, 14 Nov 2014 03:45:39 +0000
Trending Topics
Recently Viewed Topics
© 2015